How to choose a marketing agency for a peptide company
An agency is one of six ways to buy demand for a research peptide brand: hire in-house, a generalist agency, a specialist agency, an affiliate or influencer network, a freelancer, or run it yourself. In this category the decision is really about who holds the account risk. Here is what each costs and when each is wrong.
Last updated
Who is this page written for?
The founder, owner or head of growth at a US brand selling research peptides for research use from its own website, already running paid ads or trying to.
It is not written for clinics, telehealth or compounding pharmacies, and it is not written for anyone selling explicitly for human use. It is about buying demand: who can run paid acquisition without your account being restricted, what each option costs, and what to ask before you sign.
We are one of the six options and we sell one of them. The row is marked, and so is the price.
What are your six options, and what does each one cost?
The cost column is the least useful one here, because four of the six options publish no price at all. The last column is the one to read first.
| Option | How you pay | What it costs | Right when | Wrong when |
|---|---|---|---|---|
| Hire in-house | Salary, payroll taxes and benefits, paid whether or not an ad is approved. | US median annual wage May 2025: $166,790 for marketing managers, $133,660 for advertising and promotions managers, before payroll taxes and benefits. | You run enough spend that a salary is a small share of it, and you can afford the months it takes one person to learn what this category's review actually rejects. | You are hiring the salary to solve a policy problem. A new marketer will learn the policy the same way everyone does, by getting your account restricted. |
| A generalist agency | A monthly retainer, or a percentage of what you spend. | Rarely published. Ask for a sample invoice from a current client. | You want the whole marketing function run, and paid social is a small part of what you need. | Your ads and your account are the problem. A generalist will write the copy the category writes by default, which is the copy that gets rejected. |
| A specialist agency | A monthly retainer. Check whether media is routed through their accounts or yours. | Rarely published. Our offer Wealth Marketing AI is $5,000 a month flat, month to month, and the brand owns every account, page and pixel. | Rejections and restrictions are costing you revenue or your own time, and you want the creative and the pages rebuilt so review passes them rather than argued with after the fact. | The specialist's pitch is that they know how to get an ad past review. That is the account risk you already have, resold to you as a service. |
| An affiliate or influencer network | A percentage of tracked sales, or a flat fee per creator. | Rarely published, and the rate is usually negotiated per creator. | You want reach without holding the ad account risk yourself, and you have the capacity to review what every creator says about the product before it goes live. | You do not review what is said. In this category the claim is the liability, and a creator writing a benefit into a caption puts it on your brand, your site and eventually your ad account. |
| A freelancer | A monthly retainer or an hourly rate, agreed privately. | Not published anywhere we could verify. | One channel, well defined, and you already know what compliant copy looks like well enough to check theirs. | The account structure and the rejection history live in one person's head, and this is a category where that history is most of the value. |
| Run it yourself | Media only, plus your own hours and your own account risk. | Health and fitness averaged $6.17 per click and $67.36 per lead on the 2026 LocaliQ benchmarks, against $5.42 and $66.69 across all industries. The benchmark has no research-peptide row, so treat it as a floor rather than a forecast. | You are early, the spend is small, and you would rather learn the policy on a test account than on the one your revenue depends on. | The account you are learning on is the one your revenue depends on. A restriction there is not a bad month, it is a rebuild. |
Where those figures come from
- Primary US Bureau of Labor Statistics, Occupational Outlook Handbook, May 2025 median annual wages.
- Primary The policy text both platforms publish: Meta, Drugs and Pharmaceuticals, Meta, Health and Wellness, and Google Ads healthcare and medicines. Neither uses the word peptide. Both describe the wording this category reaches for by default.
- Vendor-published LocaliQ 2026 Search Advertising Benchmarks, updated 1 June 2026.
- Ours Our own dated crawl of 411 US research-peptide storefronts, The Peptide Ad Review, 15 September 2026: of 334 readable stores, 173 carry disease, treatment or outcome wording, 96 carry dosing or human-use wording, and 73 are clean on all four copy signals.
- Not published Four of the six rows have no published market price, and the specialist row carries only ours. That is the market, not a gap in the research.
Who wrote the list you are reading?
Most pages titled "best marketing agencies for" a category are published on the website of one of the agencies on the list, and that agency is usually near the top of it.
The check takes ten seconds and you can run it on every result you open, including this one. Look at the domain in the address bar. Open its services page in a second tab. If that domain sells the same service the list is ranking, the list is an advertisement with a table in it. Then look for a named author and a date, and ask whether either is on the page at all.
We sell one of the options above. Our row sits in the table in the order the options happen to run, not at the top, and the row carries the price and the limit rather than a claim. Run the check on us too.
What should you ask any agency before you sign?
Eight questions, in this order. The first one decides more than the other seven together.
Whose Business Manager and ad accounts will the campaigns run in?
A good answer is yours, with the agency holding user access you can remove the same day. An agency running your spend through its own account means a restriction on their side takes your revenue with it, and you will not be the one appealing.
What will you refuse to advertise for us?
A good answer is a list, given without being pushed. Ours is GLP-1 compounds and PT-141, plus any dosing, human-use, disease or before-and-after language on the ad or the page behind it. A vendor with no list has not read the policies.
When an ad is rejected, what exactly happens next?
A good answer is a rejection log, a diagnosis of which policy line the copy touched, a rewrite, and an appeal where the ad was compliant and wrongly flagged. If the answer is that they know a way to get it through, stop the meeting.
Will you write claims for us, or write around the absence of claims?
A good answer is the second one. The whole craft in this category is making a product interesting using compound, form, quantity, purity as tested, testing method, certificate availability and the business facts, and nothing about what it does to a body.
What happens to the landing page a reviewer sees?
A good answer is that the reviewer and the buyer see the same page, with no exceptions, and that the agency will rewrite the page as part of the work. The ad is not the only thing reviewed.
How many other research peptide brands do you run, and do any of them sell the same compounds?
A good answer is a number and a straight yes or no. Two brands bidding on the same compound names with the same agency running both is a conflict, whatever else is said about it.
What does your weekly report contain?
A good answer includes ads submitted, approved and rejected with the reason, appeals outstanding and account status, alongside spend and cost per result. Approval rate is the leading indicator in this category and a report without it is not a report.
If we part ways, what leaves with you?
A good answer is nothing. Creative, landing pages, tracking, tag container and account structure should stay with the brand. Get it in the agreement rather than in the pitch.
What does a reviewer actually see on your own pages?
In this category the ad is rarely the only thing that fails. The page behind it is read too, and most product pages in the market carry the wording the published policies describe.
We read the home page, up to three product pages and the cart page of 411 US research-peptide storefronts on 15 September 2026 and scored nine public signals. Of the 334 that were readable, 173 carry disease, treatment or outcome wording, 96 carry dosing, injection, cycle or how-to-use wording, 208 name a GLP-1, prescription drug, SARM or anabolic, and 73 are clean on all four copy signals. The median rejection-risk score was 4 of 10.
Nothing was bought, no form was submitted and no account was created. No brand is named for a poor result. The counts, the method and the run-it-yourself instructions are in The Peptide Ad Review, and you can run the same check on your own store with any of the six options above, or with none of them.
What does a marketing agency for a peptide company cost?
Almost nobody in this category publishes a price. The two public figures worth anchoring on are the salary comparison, a US median annual wage of $166,790 for marketing managers in May 2025, and media cost, $6.17 per click for health and fitness on the 2026 LocaliQ benchmarks. For agency fees, ask for a sample invoice from a current client.
For reference, Wealth Marketing AI charges a flat $5,000 a month, month to month, and the brand owns every account, page and pixel.
Why do peptide ads get rejected?
Usually because of the wording rather than the product. Meta's Drugs and Pharmaceuticals and Health and Wellness standards and Google's healthcare and medicines policy describe the language a research-peptide product page reaches for by default: what a compound does to a body, how it is used, and named prescription drug families.
Our own crawl of 334 readable US storefronts on 15 September 2026 found 173 carrying disease, treatment or outcome wording, 96 carrying dosing or human-use wording, and 159 carrying a research-use line and outcome claims on the same site. The counts and the method are in The Peptide Ad Review.
Should I hire an agency that says it can get ads past review?
No. That pitch is the risk you already have, sold back to you as a service. The thing being offered is the account restriction, just later and with a monthly fee attached.
The only durable version of this work is copy and pages that pass review as written, an account kept clean, and a proper appeal when something compliant is wrongly flagged.
Is a specialist worth it, or should a generalist handle this?
A generalist is the right answer when you need the whole marketing function and paid social is a small part of it. A specialist is worth the premium when rejections and restrictions are the thing costing you money, because the value is the accumulated knowledge of which sentences trigger which review, and a generalist has to buy that knowledge with your account.
Either way, the account has to be in your name. That is not a specialist question, it is a survival question.
Can I just run it myself?
Yes, and plenty of brands do. The cost is media plus your own hours, and the real risk is that the account you are learning on is the one your revenue depends on. A restriction there is not a bad month, it is a rebuild.
If you do, the cheapest first move is to read your own product pages against the published policy text rather than your ads.
How do I tell whether a best agencies list in this category is independent?
Look at the domain publishing it and open its services page. In this category the most-cited lists sit on the websites of agencies that also sell peptide marketing, and those agencies tend to appear near the top of their own lists.
This page is published by a company that sells one of the six options on it. Run the same check here.
If the specialist row is the one you want, this is what booking a call gets you.
Twenty minutes on your current rejections, what your own product pages say, and whether the fix is copy, pages, account structure or all three. If your catalogue is mostly compounds we will not advertise, we will say so on the call.